BCR and cancer: Nevertheless, traditional PSA measurements often fail to accurately detect BCR at low PSA levels, which requires the use of prostate-specific antigen membrane positron-emission tomography (PSMA-PET) tracers to determine whether the cancer is locally recurrent or has metastasized.5